drugset / Trial / NCT02051023

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

NCT02051023

Phase 3 Completed 41 enrolled Institute of Applied Ophthalmobiology - IOBA
RandomizedParallel-groupDouble-blindTreatment

Summary

Hypothesis: Fluorometholone (FML) 0.1% eyedrops topically applied 4 times a day for 22 days is more efficient than artificial tears (Liquifilm) in dry eye disease (DED) and ameliorates the worsening of the disease after exposure to an adverse controlled environment.

Timeline

Start
2014-02
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorometholone Other / unclassified 0.1 % Topical
Comparator Liquifilm Unknown Topical

Indications